JP4639052B2 - 性腺機能改善剤 - Google Patents

性腺機能改善剤 Download PDF

Info

Publication number
JP4639052B2
JP4639052B2 JP2004068255A JP2004068255A JP4639052B2 JP 4639052 B2 JP4639052 B2 JP 4639052B2 JP 2004068255 A JP2004068255 A JP 2004068255A JP 2004068255 A JP2004068255 A JP 2004068255A JP 4639052 B2 JP4639052 B2 JP 4639052B2
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
polypeptide
receptor
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2004068255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005097237A5 (enExample
JP2005097237A (ja
Inventor
徹也 大瀧
久典 松井
寛和 松本
千恵子 北田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to JP2004068255A priority Critical patent/JP4639052B2/ja
Publication of JP2005097237A publication Critical patent/JP2005097237A/ja
Publication of JP2005097237A5 publication Critical patent/JP2005097237A5/ja
Application granted granted Critical
Publication of JP4639052B2 publication Critical patent/JP4639052B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2004068255A 2003-03-12 2004-03-11 性腺機能改善剤 Expired - Lifetime JP4639052B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004068255A JP4639052B2 (ja) 2003-03-12 2004-03-11 性腺機能改善剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003067283 2003-03-12
JP2003311892 2003-09-03
JP2004068255A JP4639052B2 (ja) 2003-03-12 2004-03-11 性腺機能改善剤

Publications (3)

Publication Number Publication Date
JP2005097237A JP2005097237A (ja) 2005-04-14
JP2005097237A5 JP2005097237A5 (enExample) 2007-04-19
JP4639052B2 true JP4639052B2 (ja) 2011-02-23

Family

ID=34468253

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004068255A Expired - Lifetime JP4639052B2 (ja) 2003-03-12 2004-03-11 性腺機能改善剤

Country Status (1)

Country Link
JP (1) JP4639052B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2009131191A1 (ja) * 2008-04-24 2011-08-25 武田薬品工業株式会社 メタスチン誘導体およびその用途
IL265696B2 (en) * 2016-09-30 2024-08-01 Sumitomo Pharma Switzerland Gmbh 2-(n-acetyl-d-tyrosyl-trans-4-hydroxy-l-prolyl-l-asparaginyl-l-threonyl-l-phenylalanyl) hydrazinocarbonyl-l-leucyl-nω-methyl-l-arginyl-l-tryptophanamide, for use in assisted reproductive technology.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4486187B2 (ja) * 1998-10-27 2010-06-23 武田薬品工業株式会社 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド
JP2001340094A (ja) * 2000-03-30 2001-12-11 Takeda Chem Ind Ltd 新規蛋白質、そのｄｎａおよびその製造法
JP2003002841A (ja) * 2001-04-20 2003-01-08 Takeda Chem Ind Ltd ペプチド含有製剤

Also Published As

Publication number Publication date
JP2005097237A (ja) 2005-04-14

Similar Documents

Publication Publication Date Title
US20110052563A1 (en) Gonadal function improving agents
US7556926B2 (en) Methods for screening insulin-sensitizing agents
EP1239039A1 (en) Novel polypeptide and dna thereof
JP5317318B2 (ja) 新規ポリペプチドおよびその用途
JP4639052B2 (ja) 性腺機能改善剤
EP1191096A1 (en) Novel protein and dna thereof
JP4184875B2 (ja) 新規スクリーニング方法
JP2004073182A (ja) インスリン抵抗性改善剤
JP4184697B2 (ja) スクリーニング方法
EP1600165A1 (en) Medicinal use of mip-3alpha inhibitor and method of screening brain/nerve cell protective agent
JP4761812B2 (ja) マスクリン受容体およびその用途
JP4353697B2 (ja) がんの予防・治療剤
JP4445291B2 (ja) 新規タンパク質およびそのｄｎａ
JP4676608B2 (ja) 新規タヒキニン様ポリペプチドおよびその用途
JP2004198202A (ja) 新規スクリーニング方法
JP4300008B2 (ja) 新規タンパク質およびそのｄｎａ
JP4167868B2 (ja) 新規分泌蛋白質およびそのｄｎａ
JP4320355B2 (ja) 新規Ｆａｓリガンド様タンパク質およびそのＤＮＡ
EP1602380A1 (en) Preventive/remedy for diseases in upper digestive tract
JP2004173677A (ja) 新規タンパク質およびそのｄｎａ
JP2004089182A (ja) がんの予防・治療剤
JP2005210924A (ja) アルカデイン結合タンパク質およびその用途
JPWO2006101273A1 (ja) 癌の予防・治療剤
EP1300467A1 (en) Novel polypeptide and dna thereof
JP2004323506A (ja) ＭＩＰ−３α抑制薬の医薬用途および脳・神経細胞保護剤のスクリーニング方法

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20061011

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070302

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070302

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100625

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100727

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100831

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20101021

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101116

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101129

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131203

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4639052

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131203

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term